35
https://pubmed.ncbi.nlm.nih.gov/38117356
Aspirin use in patients with inflammatory bowel disease may be associated with a reduced risk of mortality, sepsis, and shock.
“Aspirin use and reduced risk of mortality, sepsis, and shock in inflammatory bowel disease patients”
